[{"uuid": "fc2b055c-6da9-3c13-9fb7-491bc3c9cf47", "title": "CMRX Stock Skyrockets in 3 Months: Here's What You Should Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/cmrx-stock-skyrockets-3-months-154300643.html", "providerPublishTime": 1738338180, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wYQLwM.yHAc_hHptSu_lhQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/eA5p1GotBcGPlbcSkQjmLA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/701e76528de32ecfd8ed3df2f647e9a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "f099b905-dd00-370a-8ce9-9855312226de", "title": "Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/chimerix-present-jonestrading-virtual-precision-211500006.html", "providerPublishTime": 1738185300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xGUSJISAFp2vJlCGq_LJCg--~B/aD0zODt3PTEzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 134, "height": 38, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7Ny.lQ3eG2Pu_fzX744IYg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "6c62f05e-7b3e-392e-8a10-efe7f04adb06", "title": "Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/chimerix-reports-inducement-grants-under-210100462.html", "providerPublishTime": 1737752460, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xGUSJISAFp2vJlCGq_LJCg--~B/aD0zODt3PTEzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 134, "height": 38, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7Ny.lQ3eG2Pu_fzX744IYg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "47c66ba5-72fc-3ab8-b4a1-fab7496bb416", "title": "US Penny Stocks To Watch In January 2025", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/us-penny-stocks-watch-january-000501342.html", "providerPublishTime": 1737072301, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CGOxaHjnDUfozYQ8rIP9ZA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/de08ce5a09ed74f962345d43f617cd22", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/j8rr.dvMKaP8uW9sU8pg6g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/de08ce5a09ed74f962345d43f617cd22", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX", "CRGO", "CRGOW"]}, {"uuid": "0a78e964-e799-31ea-8b80-6be0913b14c8", "title": "Here\u2019s Why Chimerix, Inc. (CMRX) Is Skyrocketing", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-chimerix-inc-cmrx-skyrocketing-212153927.html", "providerPublishTime": 1736803313, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VdQzcpwnIq3v5IPkcJP0Bw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/d22057b8fa94f2a933dcc97dcbeffa99", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/C5koPyDegml3VtAtbgNg3w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/d22057b8fa94f2a933dcc97dcbeffa99", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "6df72b48-7729-3187-8779-1d68a6d75a5d", "title": "Chimerix to Speak Today at The White House Cancer Moonshot Forum", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/chimerix-speak-today-white-house-120000327.html", "providerPublishTime": 1736769600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xGUSJISAFp2vJlCGq_LJCg--~B/aD0zODt3PTEzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 134, "height": 38, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7Ny.lQ3eG2Pu_fzX744IYg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "680c2c6c-dab5-3559-a247-108fbb367955", "title": "Chimerix Seeks Accelerated FDA Approval for Experimental Tumor Drug", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/chimerix-seeks-accelerated-fda-approval-122643275.html", "providerPublishTime": 1735561603, "type": "STORY", "relatedTickers": ["CMRX"]}, {"uuid": "e30efb53-1fec-37e4-9989-6337719e5319", "title": "Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/chimerix-submits-dordaviprone-drug-application-120000746.html", "providerPublishTime": 1735560000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xGUSJISAFp2vJlCGq_LJCg--~B/aD0zODt3PTEzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 134, "height": 38, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7Ny.lQ3eG2Pu_fzX744IYg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/a065a286fd49392aeb577f68f86799b5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "c53a05be-0567-320f-9fcc-e4e481a48857", "title": "Chimerix (CMRX) Reports Q3 Loss, Lags Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/chimerix-cmrx-reports-q3-loss-133505561.html", "providerPublishTime": 1730986505, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/syGPuhdcxJrEtuZed80ilQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}, {"uuid": "30167d07-a437-3257-b8ce-531299ff0ef3", "title": "Top Midday Gainers", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-midday-gainers-180511909.html", "providerPublishTime": 1733853911, "type": "STORY", "relatedTickers": ["CMRX"]}, {"uuid": "a9cdceca-85cb-3e29-8478-6abfe8062a1c", "title": "Chimerix Shares Soar Following Plans to Seek Accelerated Approval for Dordaviprone in Rare Brain Tumor", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/chimerix-shares-soar-following-plans-183317934.html", "providerPublishTime": 1733855597, "type": "STORY", "relatedTickers": ["CMRX"]}, {"uuid": "930fb645-777e-3736-9bd3-40a3dbbbbec9", "title": "Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/why-cancer-focused-chimerix-stock-143934294.html", "providerPublishTime": 1733841574, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UaiQ1KxMws7rGvmQ.673FQ--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/5e51e0b5950c40b10ba3f37b491c11d6", "width": 983, "height": 553, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uxOfj2x_UjWeuBDmAwFjdQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/5e51e0b5950c40b10ba3f37b491c11d6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CMRX"]}]